MMWR News Synopsis
Friday, January 15, 2021
- Cancer Screening Test Receipt – United States, 2018
- CDC’s Emergency Management Program Activities — Worldwide, 2013–2018
- Assessment of Neonatal Abstinence Syndrome Surveillance – Pennsylvania, 2019
- Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020 (Early Release January 6, 2021)
- Rates of COVID-19 Among Residents and Staff Members in Nursing Homes — United States, May 25–November 22, 2020 (Early Release January 8, 2021)
- Candida auris Outbreak in a COVID-19 Specialty Care Unit — Florida, July–August 2020 (Early Release January 8, 2021)
- Mitigation Policies and COVID-19–Associated Mortality — 37 European Countries, January 23–June 30, 2020 (Early Release January 12, 2021)
- QuickStats
Articles
Cancer Screening Test Receipt – United States, 2018
CDC Media Relations
404-639-3286
Screening for breast, cervical, and colorectal cancer leads to earlier clinical treatment and fewer deaths. However, breast and cervical cancer screening remained below national targets in 2018, with little change since 2005. Colorectal cancer screening use increased in recent years and has neared the target. Differences in screening continue, particularly among those that are uninsured or without a usual source of care. A new CDC study shows that screening for breast, cervical, and colorectal cancers was below national Healthy People 2020 targets in 2018. Colorectal cancer screening increased after 2005, nearing the target in 2018, but breast and cervical cancer screening remained below targets with little change over this period. Health disparities were also evident, with particularly low screening rates among people with no health insurance or without usual sources of care, with the lowest percentages of breast and colorectal cancer screening test use in these groups. CDC’s National Breast and Cervical Cancer Early Detection Program provides access to low-cost breast and cervical cancer screening and diagnostic services. The Colorectal Cancer Control Program supports implementation of evidence-based interventions to improve the appropriate use of screening tests.
CDC’s Emergency Management Program Activities — Worldwide, 2013–2018
CDC Media Relations
404-639-3286
During 2013-2018, the Centers for Disease Control and Prevention (CDC) has seen an increase in its emergency management program activities due to infectious disease outbreaks, disasters (human-made or natural), and security events. This report assessed CDC’s emergency management program activities from 2013 through 2018. During 2013-2018, CDC responded to 12 events that required support from across the agency; the two longest events during this timeframe were the 2014 Ebola and 2016 Zika responses. In 2016, CDC responded to four events simultaneously: 2011 Polio, 2014 Ebola, 2016 Zika, and the 2016 Flint Water Contamination responses. CDC was the first federal public health agency to receive full agency-wide accreditation by the Emergency Management Accreditation Program (EMAP) in 2013 and reaccreditation in December 2018, highlighting the agency’s ability to respond to domestic and global public health threats. As more complex and novel public health emergencies occur, CDC, other agencies, and programs can use and adapt the Incident Management System (IMS) to respond to various public health emergencies.
Assessment of Neonatal Abstinence Syndrome Surveillance – Pennsylvania, 2019
CDC Media Relations
404-639-3286
The quality of neonatal abstinence syndrome (NAS) surveillance could be strengthened by a combination of diagnosis code assessment and focused medical record review. Improved accuracy of surveillance could help monitor changes and regional differences in incidence and assist with planning for needed services. In five hospitals across Pennsylvania, public health scientists found that the Pennsylvania Department of Health’s NAS surveillance system identified the majority (79%) of infants with NAS. NAS is a group of conditions that can occur when newborns were exposed to certain substances, including opioids, before birth. Most infants with NAS were assigned ICD-10-CM code P96.1 (neonatal withdrawal symptoms from maternal use of drugs of addiction) whether they were reported to the surveillance system or not. The quality of NAS tracking could be strengthened by using a combination of diagnosis code assessment and medical records review. Accurate NAS surveillance is needed to monitor changes in the incidence of NAS and to help plan for needed treatment and prevention services for mothers and babies. Findings from this report may help guide NAS surveillance efforts in other states.
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020 (Early Release January 6, 2021)
CDC Media Relations
404-639-3286
Rates of COVID-19 Among Residents and Staff Members in Nursing Homes — United States, May 25–November 22, 2020 (Early Release January 8, 2021)
CDC Media Relations
404-639-3286
Candida auris Outbreak in a COVID-19 Specialty Care Unit — Florida, July–August 2020 (Early Release January 8, 2021)
CDC Media Relations
404-639-3286
Copy and paste text from the Word doc they sent you and keep the same formatting.
Mitigation Policies and COVID-19–Associated Mortality — 37 European Countries, January 23–June 30, 2020 (Early Release January 12, 2021)
CDC Media Relations
404-639-3286
###
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
CDC works 24/7 protecting America’s health, safety and security. Whether diseases start at home or abroad, are curable or preventable, chronic or acute, or from human activity or deliberate attack, CDC responds to America’s most pressing health threats. CDC is headquartered in Atlanta and has experts located throughout the United States and the world.
